Podcasts

Pharma Marketing Talk on BlogTalkRadio and Pharma Talk on SoundCloud are hosted by John Pharmaguy Mack, publisher of Pharma Marketing BlogPharma Marketing Newsand Pharma Industry News Update (PinUp). Subscribe Now! 

Access On-Demand podcasts on SoundCloud and BlogTalkRadio

You can also subscribe to the Pharma Talk RSS feed and to the Pharma Marketing Talk station on iTunes.

The Misleading Marketing of “Low-T” Drugs


A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut about the consequences of misleading marketing of hormone treatment drugs such as Androgen.



Also read this article published on LinkedIn:Abbvie misleads while AZ, Lilly, GSK engage. All are lobbying energetically!

The Forgotten eHealth Code of Ethics


Any research or effort designed to improve the quality of health information on the Internet must build upon the work already done by the creators of the international eHealth Code of Ethics, which is as relevant today as it was back in 2000.



Also read this article published on LinkedIn:
Trustworthiness & Usefulness of Web-based Health Info & Pharma Blogs

Limiting Pharma Sales Rep Access to Physicians


Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.


For more on this topic, read: 
May 5, 2017, issue of Pharma Industry News Update

A Drug By Any Other Name


In this 5-minute audio snippet, Pharmaguy discusses the naming of drugs, which has been described both as a science and an art. Whichever, some say drug names are absurd. Drug names have been laughed at on Saturday Night Live and even cited as a reason why patients do not fill their prescriptions. And it all may be due to the overuse of 2 letters in the alphabet!





For more on this topic, read: 
March 31, 2017, issue of Pharma Industry News Update